Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01420250
Title Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

prostate adenocarcinoma

Therapies

Bicalutamide

Cabazitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.